This HTML5 document contains 95 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n17https://global.dbpedia.org/id/
dbpedia-ruhttp://ru.dbpedia.org/resource/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n16http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n18https://druginfo.nlm.nih.gov/drugportal/name/
n14http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Alzheimer's_disease
dbo:wikiPageWikiLink
dbr:Flortaucipir_(18F)
Subject Item
dbr:Flortaucipir_(F18)
dbo:wikiPageWikiLink
dbr:Flortaucipir_(18F)
dbo:wikiPageRedirects
dbr:Flortaucipir_(18F)
Subject Item
dbr:Flortaucipir_F18
dbo:wikiPageWikiLink
dbr:Flortaucipir_(18F)
dbo:wikiPageRedirects
dbr:Flortaucipir_(18F)
Subject Item
dbr:Flortaucipir_(18F)
rdf:type
owl:Thing wikidata:Q8386 dbo:Drug dbo:ChemicalSubstance n16:ChemicalObject
rdfs:label
Flortaucipir (18F) Flortaucipir (18F)
rdfs:comment
Флортауципир (18F) — радиофармацевтический препарат для диагностики болезни Альцгеймера. Одобрен для применения: США (2020). Flortaucipir (18F), sold under the brand name Tauvid, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging to image the brain. The most common adverse reactions include headache, injection site pain and increased blood pressure. It is the first drug used to help image a distinctive characteristic of Alzheimer's disease in the brain called tau pathology. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
foaf:name
Flortaucipir (18F)
foaf:depiction
n14:Flortaucipir.png
dcterms:subject
dbc:Alzheimer's_disease dbc:PET_radiotracers dbc:Radiopharmaceuticals dbc:Medicinal_radiochemistry
dbo:wikiPageID
64105317
dbo:wikiPageRevisionID
1117137976
dbo:wikiPageWikiLink
dbr:Positron_emission_tomography dbr:PET_radiotracer dbr:Amyloid dbc:Alzheimer's_disease dbr:International_nonproprietary_name dbr:Intravenous_injection dbr:Alzheimer's_disease dbr:Medical_imaging dbr:Food_and_Drug_Administration dbc:PET_radiotracers dbr:Priority_review dbc:Radiopharmaceuticals dbr:Neurofibrillary_tangle dbr:Tau_protein dbr:First-in-class_medication dbc:Medicinal_radiochemistry
dbo:wikiPageExternalLink
n18:flortaucipir%20f%2018
owl:sameAs
dbpedia-ru:Flortaucipir_(18F) wikidata:Q21936669 n17:24yZE
dbp:usan
flortaucipir F 18
dbp:wikiPageUsesTemplate
dbt:Use_American_English dbt:Diagnostic_radiopharmaceuticals dbt:Infobox_drug dbt:Reflist dbt:Cite_web dbt:Cite_journal dbt:Use_dmy_dates dbt:ClinicalTrialsGov dbt:Portal_bar
dbo:thumbnail
n14:Flortaucipir.png?width=300
dbp:atcPrefix
None
dbp:casNumber
1522051
dbp:chembl
3545253
dbp:chemspiderid
32701063
dbp:drugName
Flortaucipir
dbp:drugbank
DB14914
dbp:iupacName
7
dbp:kegg
D11210
dbp:legalUs
Rx-only
dbp:molecularWeight
262.27
dbp:pubchem
70957463
dbp:routesOfAdministration
dbr:Intravenous_injection
dbp:smiles
C1=CC2=CNC4=C2C=NC=C4
dbp:stdinchi
1
dbp:stdinchikey
GETAAWDSFUCLBS-SJPDSGJFSA-N
dbp:synonyms
18
dbp:tradename
Tauvid
dbp:unii
T1JP1KYU9O
dbo:abstract
Флортауципир (18F) — радиофармацевтический препарат для диагностики болезни Альцгеймера. Одобрен для применения: США (2020). Flortaucipir (18F), sold under the brand name Tauvid, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging to image the brain. The most common adverse reactions include headache, injection site pain and increased blood pressure. Two proteins – tau and amyloid – are recognized as hallmarks of Alzheimer's disease. In people with Alzheimer's disease, pathological forms of tau proteins develop inside neurons in the brain, creating neurofibrillary tangles. After flortaucipir (18F) is administered intravenously, it binds to sites in the brain associated with this tau protein misfolding. The brain can then be imaged with a PET scan to help identify the presence of tau pathology. It is the first drug used to help image a distinctive characteristic of Alzheimer's disease in the brain called tau pathology. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
dbp:chemicalFormula
C16H10[18F]N3
dbp:dailymedid
Flortaucipir
dbp:licenceUs
Tauvid
dbp:pronounce
flor tau' si pir 18 F
dbo:chemicalFormula
C16H10[18F]N3
prov:wasDerivedFrom
wikipedia-en:Flortaucipir_(18F)?oldid=1117137976&ns=0
dbo:wikiPageLength
12427
dbo:alternativeName
Tauvid
dbo:casNumber
1522051-90-6
dbo:chEMBL
3545253
dbo:drugbank
DB14914
dbo:fdaUniiCode
T1JP1KYU9O
dbo:kegg
D11210
dbo:pubchem
70957463
foaf:isPrimaryTopicOf
wikipedia-en:Flortaucipir_(18F)
Subject Item
dbr:Flortaucipir_F-18
dbo:wikiPageWikiLink
dbr:Flortaucipir_(18F)
dbo:wikiPageRedirects
dbr:Flortaucipir_(18F)
Subject Item
dbr:Tauvid
dbo:wikiPageWikiLink
dbr:Flortaucipir_(18F)
dbo:wikiPageRedirects
dbr:Flortaucipir_(18F)
Subject Item
dbr:Flortaucipir_F_18
dbo:wikiPageWikiLink
dbr:Flortaucipir_(18F)
dbo:wikiPageRedirects
dbr:Flortaucipir_(18F)
Subject Item
wikipedia-en:Flortaucipir_(18F)
foaf:primaryTopic
dbr:Flortaucipir_(18F)